in Newswire Published on December 9, 2019

Following FDA Warning, ‘Mislabeled’ Koi CBD Products Subject of Class Action

Fausett et al. v. Koi CBD, LLC

Filed: December 5, 2019 § 2:19-cv-10318

A class action alleges Koi CBD's products are illegal in that they're systematically mislabeled and mismarketed for purposes unapproved by the FDA.






Case Spotlight

Camp Lejeune Newsletter

Stay Current

Sign Up For
Our Newsletter

New cases and investigations, settlement deadlines, and news straight to your inbox.

This browser does not support PDFs. Please download the PDF to view it: Download PDF.

Last Updated on December 9, 2019 — 3:57 PM

Corrado Rizzi

Corrado Rizzi is the Managing Editor and a writer for

About is a group of online professionals (designers, developers and writers) with years of experience in the legal industry.

Learn More

Before commenting, please review our comment policy.